Your session is about to expire
← Back to Search
Community Pharmacy Assisting in Total Cardiovascular Health (CPATCH Trial)
N/A
Waitlist Available
Research Sponsored by University of Saskatchewan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
Despite proven benefits in reducing morbidity and mortality, many patients become nonadherent to statin therapy within the first year of starting. Due to their accessibility and frequent patient contact, pharmacists are well-positioned to improve medication adherence. The purpose of this study is to determine whether a simple intervention by community pharmacists can improve statin adherence in new statin users.
Eligible Conditions
- Statin Therapy
- Compliance
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mean statin adherence among all eligible new users of statin medications with at least 6 months of follow-up from index prescription
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Pharmacy Intervention ArmExperimental Treatment1 Intervention
All patients receiving statins from pharmacies allocated to the pharmacist intervention arm of the study
Group II: Usual CareActive Control1 Intervention
Pharmacies not allocated to the intervention arm will serve as the control. They received no training on the CPATCH intervention and provide usual care to patients at their pharmacy.
Find a Location
Who is running the clinical trial?
Saskatchewan Ministry of HealthUNKNOWN
3 Previous Clinical Trials
592 Total Patients Enrolled
University of SaskatchewanLead Sponsor
257 Previous Clinical Trials
153,841 Total Patients Enrolled
Ministry of Health, SaskatchewanOTHER
3 Previous Clinical Trials
592 Total Patients Enrolled
Merck Frosst Canada Ltd.Industry Sponsor
29 Previous Clinical Trials
10,157 Total Patients Enrolled